PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medical Oncology, Mohammed VI University Hospital, Oujda, Morocco. Electronic address: k.elbairi@ump.ac.ma.\', \'European Institute of Oncology, IRCCS, Milan, Italy.\', \'Medical Oncology Unit, Ospedale del Mare, Naples, Italy; University of Study of Campania \'L.Vanvitelli\', Naples, Italy.\', \'Research Institute of McGill University Health Center (RI-MUHC), Montréal, QC, Canada.\', \'Center of Marine Sciences, University of Algarve, Ed. 7, Campus of Gambelas, 8005-139, Faro, Portugal.\', \'Medical Oncology Unit, Ospedale del Mare, Naples, Italy.\', \'Department of Medical Oncology, \'Bioscience et Santé\' Research Laboratory, Faculty of Medicine, Cadi Ayad University, Marrakesh, Morocco.\', \'European Institute of Oncology, IRCCS, Milan, Italy; University of Milan, Department of Oncology and Hematology, Milan, Italy.\', \'Department of Medical Oncology, Mohammed VI University Hospital, Oujda, Morocco.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0959-8049(20)30520-710.1016/j.ejca.2020.09.014
?:doi
?:hasPublicationType
?:journal
  • European journal of cancer (Oxford, England : 1990)
is ?:pmid of
?:pmid
?:pmid
  • 33125946
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Repurposing anticancer drugs for the management of COVID-19.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33125946>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33125946>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all